Literature DB >> 28846165

A Trishistidine Pseudopeptide with Ability to Remove Both CuΙ and CuΙΙ from the Amyloid-β Peptide and to Stop the Associated ROS Formation.

Amandine Conte-Daban1,2, Bastien Boff3, Andreza Candido Matias3,4, Claudia N Montes Aparicio1,2, Christelle Gateau3, Colette Lebrun3, Giselle Cerchiaro4, Isabelle Kieffer5,6, Stéphanie Sayen7, Emmanuel Guillon7, Pascale Delangle3, Christelle Hureau1,2.   

Abstract

The pseudopeptide L, derived from a nitrilotriacetic acid scaffold and functionalized with three histidine moieties, is reminiscent of the amino acid side chains encountered in the Alzheimer's peptide (Aβ). Its synthesis and coordination properties for CuΙ and CuΙΙ are described. L efficiently complex CuΙΙ in a square-planar geometry involving three imidazole nitrogen atoms and an amidate-Cu bond. By contrast, CuΙ is coordinated in a tetrahedral environment. The redox behavior is irreversible and follows an ECEC mechanism in accordance with the very different environments of the two redox states of the Cu center. This is in line with the observed resistance of the CuΙ complex to oxidation by oxygen and the CuΙΙ complex reduction by ascorbate. The affinities of L for CuΙΙ and CuΙ at physiological pH are larger than that reported for the Aβ peptide. Therefore, due to its peculiar Cu coordination properties, the ligand L is able to target both redox states of Cu, redox silence them and prevent reactive oxygen species production by the CuAβ complex. Because reactive oxygen species contribute to the oxidative stress, a key issue in Alzheimer's disease, this ligand thus represents a new strategy in the long route of finding molecular concepts for fighting Alzheimer's disease.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Alzheimer's disease; bioinorganic chemistry; copper; ligand design; peptides

Mesh:

Substances:

Year:  2017        PMID: 28846165      PMCID: PMC5714062          DOI: 10.1002/chem.201703429

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  80 in total

1.  Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity.

Authors:  Xiaoyu Hu; Qian Zhang; Wei Wang; Zhi Yuan; Xushan Zhu; Bing Chen; Xingyu Chen
Journal:  ACS Chem Neurosci       Date:  2016-08-03       Impact factor: 4.418

2.  Feedback system of a liquid-nitrogen-cooled double-crystal monochromator: design and performances.

Authors:  Olivier Proux; Vivian Nassif; Alain Prat; Olivier Ulrich; Eric Lahera; Xavier Biquard; Jean Jacques Menthonnex; Jean Louis Hazemann
Journal:  J Synchrotron Radiat       Date:  2005-12-22       Impact factor: 2.616

3.  Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.

Authors:  Anne Robert; Yan Liu; Michel Nguyen; Bernard Meunier
Journal:  Acc Chem Res       Date:  2015-05-06       Impact factor: 22.384

Review 4.  Copper active sites in biology.

Authors:  Edward I Solomon; David E Heppner; Esther M Johnston; Jake W Ginsbach; Jordi Cirera; Munzarin Qayyum; Matthew T Kieber-Emmons; Christian H Kjaergaard; Ryan G Hadt; Li Tian
Journal:  Chem Rev       Date:  2014-03-03       Impact factor: 60.622

5.  Supramolecular modeling of mono-copper enzyme active sites with calix[6]arene-based funnel complexes.

Authors:  Nicolas Le Poul; Yves Le Mest; Ivan Jabin; Olivia Reinaud
Journal:  Acc Chem Res       Date:  2015-06-23       Impact factor: 22.384

6.  Cu(II) affinity for the Alzheimer's peptide: tyrosine fluorescence studies revisited.

Authors:  Bruno Alies; Emelyne Renaglia; Malgorzata Rózga; Wojciech Bal; Peter Faller; Christelle Hureau
Journal:  Anal Chem       Date:  2013-01-09       Impact factor: 6.986

7.  Molecular scale speciation of first-row transition elements bound to ligneous material by using X-ray absorption spectroscopy.

Authors:  Emmanuel Guillon; Patricia Merdy; Michel Aplincourt
Journal:  Chemistry       Date:  2003-09-22       Impact factor: 5.236

8.  X-ray absorption spectroscopy proves the trigonal-planar sulfur-only coordination of copper(I) with high-affinity tripodal pseudopeptides.

Authors:  Anne-Solène Jullien; Christelle Gateau; Isabelle Kieffer; Denis Testemale; Pascale Delangle
Journal:  Inorg Chem       Date:  2013-08-12       Impact factor: 5.165

9.  A bioinorganic view of Alzheimer's disease: when misplaced metal ions (re)direct the electrons to the wrong target.

Authors:  Peter Faller; Christelle Hureau
Journal:  Chemistry       Date:  2012-11-23       Impact factor: 5.236

10.  The Necessity of Having a Tetradentate Ligand to Extract Copper(II) Ions from Amyloids.

Authors:  Michel Nguyen; Lionel Rechignat; Anne Robert; Bernard Meunier
Journal:  ChemistryOpen       Date:  2014-10-27       Impact factor: 2.911

View more
  3 in total

1.  Crystal structure of catena-poly[[[di-chlorido-copper(II)]-{μ-tert-butyl N-methyl-N-[4-(6-{[4-(pyridin-2-yl-κN)-1H-1,2,3-triazol-1-yl-κN3]meth-yl}-1,3-benzo-thia-zol-2-yl)phen-yl]carbamato}] aceto-nitrile monosolvate].

Authors:  Alexandre Pocinho; Carine Duhayon; Emmanuel Gras; Christelle Hureau
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2018-01-12

2.  A Metallo Pro-Drug to Target CuII in the Context of Alzheimer's Disease.

Authors:  Amandine Conte-Daban; Vinita Ambike; Régis Guillot; Nicolas Delsuc; Clotilde Policar; Christelle Hureau
Journal:  Chemistry       Date:  2018-02-16       Impact factor: 5.236

3.  Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.

Authors:  Marielle Drommi; Clément Rulmont; Charlène Esmieu; Christelle Hureau
Journal:  Molecules       Date:  2021-12-16       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.